Table 2 Logistic regression analyses for predictors of a favorable functional outcome.
From: Impact of brain atrophy on 90-day functional outcome after moderate-volume basal ganglia hemorrhage
| Â | Favorable outcome | ||||
|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | ||||
OR | P-value | OR | 95% CI | P-value | |
Age | 0.979 | 0.186 | 0.869 | 0.812â0.931 | <0.001 |
History of hypertension | 1.346 | 0.418 | Â | Â | Â |
Previous ICH | 1.135 | 0.866 | Â | Â | Â |
Previous ischemic stroke | 0.657 | 0.566 | Â | Â | Â |
Antihypertensive use | 1.329 | 0.485 | Â | Â | Â |
Antithrombotic use | 0.652 | 0.518 | Â | Â | Â |
Dominant hemisphere | 0.406 | 0.016 | 0.904 | 0.301â2.718 | 0.857 |
GCS score | 1.597 | <0.001 | 1.311 | 1.019â1.686 | 0.035 |
Hematoma volume | 0.947 | 0.006 | 0.941 | 0.888â0.997 | 0.041 |
ICD | 1.204 | 0.001 | 1.207 | 1.004â1.451 | 0.045 |
SFR, per 0.001 | 1.034 | 0.002 | 1.046 | 1.007â1.086 | 0.021 |
Surgical treatment | 0.200 | 0.001 | 0.374 | 0.080â1.742 | 0.210 |